[Updated acute community-acquired pneumonia in adults: Guidelines for initial antimicrobial therapy based on local evidence from the South American Working Group (ConsenSur II)]
- PMID: 20737129
[Updated acute community-acquired pneumonia in adults: Guidelines for initial antimicrobial therapy based on local evidence from the South American Working Group (ConsenSur II)]
Abstract
Community-acquired pneumonia (CAP) in adults is probably one of the infections affecting ambulatory patients for which the highest diversity of guidelines has been written worldwide. Most of them agree in that antimicrobial therapy should be initially tailored according to either the severity of the infection or the presence of comorbidities and the etiologic pathogen. Nevertheless, a great variability may be noted among the different countries in the selection of the primary choice in the antimicrobial agents, even for the cases considered as at a low-risk class. This fact may be due to the many microbial causes of CAP and specialties involved, as well as the different health-care systems effecting on the availability or cost of antibiotics. However, many countries or regions adopt some of the guidelines or design their own recommendations regardless of the local data, probably because of the scarcity of such data. This is the reason why we have developed a guideline for the initial treatment of CAP by 2002 upon the basis of several local evidences in South América (ConsenSur I). However, several issues deserve to be currently rediscussed as follows: certain clinical scores other than the Physiological Severity índex (PSI) have become more popular in clinical practice (i.e. CURB-65, CRB-65); some pathogens have emerged in the región, such as community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) and Legionella spp; new evidences on the performance of the rapid test for the etiologic diagnosis in CAP have been reported (eg. urinary Legionella andpneumococcus antigens); new therapeutic considerations needs to be approached (i.e. dosage reformulation, duration of treatment, emergence of novel antibiotics and clinical impact of combined therapy). Like in the first versión of the ConsenSur (ConsenSur I), the various current guidelines have helped to organize and stratify the present proposal, ConsenSur II.
Similar articles
-
Acute community-acquired pneumonia in adults: guidelines for initial antimicrobial therapy based on local evidence from a South American Working Group (ConsenSur).J Chemother. 2002 Dec;14 Suppl 4:1-22. doi: 10.1080/1120009x.2002.11782352. J Chemother. 2002. PMID: 12680511
-
Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia.Neth J Med. 2005 Sep;63(8):323-35. Neth J Med. 2005. PMID: 16186645 Review.
-
[Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].Ned Tijdschr Geneeskd. 2005 Nov 5;149(45):2495-500. Ned Tijdschr Geneeskd. 2005. PMID: 16304886 Review. Dutch.
-
Community acquired bacterial pneumonia.Expert Opin Pharmacother. 2010 Feb;11(3):361-74. doi: 10.1517/14656560903508770. Expert Opin Pharmacother. 2010. PMID: 20085502 Review.
-
Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia.Semin Respir Infect. 1997 Dec;12(4):308-21. Semin Respir Infect. 1997. PMID: 9436958 Review.
Cited by
-
In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study.Infect Dis Ther. 2016 Jun;5(2):139-53. doi: 10.1007/s40121-016-0112-3. Epub 2016 Jun 10. Infect Dis Ther. 2016. PMID: 27287766 Free PMC article.
-
Etiology, clinical, and epidemiological characteristics of severe respiratory infection in people living with HIV.Int J STD AIDS. 2020 Feb;31(2):100-108. doi: 10.1177/0956462419882587. Epub 2020 Jan 22. Int J STD AIDS. 2020. PMID: 31969059 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous